Carlos De Sousa
Carlos de Sousa is Vice President Corporate Licensing, Business Development at Nycomed and responsible for the company’s global in-licensing activities.
Dr. de Sousa joined Nycomed International Management GmbH in February 2009. He brought with him experience from Newron Pharmaceuticals SpA in Italy, where he was Chief Business Officer responsible for the company’s growth strategy, including its in- and out-licensing, and mergers & acquisitions activities. Previously, he was Global Head of Business Development and Licensing at Schwarz Pharma AG in Germany. Prior to that Dr. de Sousa served as Head of Global Negotiations Neuroscience and Region Europe Business Franchise Head Respiratory & Dermatology for Novartis Pharma AG, based in Switzerland. In 1989 he started his career in the pharmaceutical industry with Pfizer as Medical Director in Portugal. He then joined the Pfizer Corporation in New York, USA, where he was initially appointed International Medical Director, and subsequently Director Corporate Licensing & Development, and Director Medical and Regulatory Affairs for Latin America. Dr. de Sousa got his Medical Doctor degree from Lisbon University in 1983 and his Executive MBA from New York University in 2000.
or